1247119-36-3 Usage
Uses
As the provided materials do not explicitly list the uses of (S)-ethyl-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanoate oxalate, it is not possible to provide a detailed list of applications based on the information given. However, given the complexity of its structure, it is likely that (S)-ethyl-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanoate oxalate may have potential applications in various fields such as pharmaceuticals, materials science, or chemical research, where its unique properties could be harnessed for specific purposes. Further investigation by a professional chemist would be necessary to determine its exact uses and potential applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1247119-36-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,7,1,1 and 9 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1247119-36:
(9*1)+(8*2)+(7*4)+(6*7)+(5*1)+(4*1)+(3*9)+(2*3)+(1*6)=143
143 % 10 = 3
So 1247119-36-3 is a valid CAS Registry Number.
1247119-36-3Relevant academic research and scientific papers
NOVEL PROCESS FOR THE PREPARATION OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5- CARBAMOYL) AMINO] -4-(MORPHOLIN-4-YL)BUTANOYL]AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE
-
Paragraph 0169, (2018/02/28)
The present invention relates to novel processes for the preparation 1,3-Thiazol-5-ylmethyl[(2R,5R)-5-{[(2S)-2-[(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl} carbamoyl)amino]-4-(morpholin-4-yl)butanoyl]amino}-1,6-diphenylhexan-2-yl] carbamate having the following structural formula-1 and it's intermediates thereof.
PREPARATION OF COBICISTAT INTERMEDIATES
-
Page/Page column 14, (2015/06/18)
The present disclosure provides crystalline piperidine sulfamoyl intermediates of formula 8 and 9. The present disclosure also relates to an improved process for the preparation of cobicistat using compounds of formulae 8 and 9.
METHODS AND INTERMEDIATES FOR PREPARING PHARMACEUTICAL AGENTS
-
Page/Page column 21, (2010/10/19)
The invention provides methods and intermediates that are useful for preparing a compound of formula I: and salts thereof.
